Q1 2024 Holdings
Filed 2024-05-15 | 38 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $564.4M | 8,493,321 | 26.8% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $140.2M | 4,400,000 | 6.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $116.1M | 12,762,462 | 5.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $82.4M | 2,171,782 | 3.9% |
| Merus N V | COM | N5749R100 | $80.6M | 1,790,214 | 3.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $78.5M | 3,395,606 | 3.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $74.1M | 6,249,731 | 3.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $70.8M | 4,026,331 | 3.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $68.0M | 3,882,671 | 3.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $62.8M | 2,094,373 | 3.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $61.7M | 2,173,913 | 2.9% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $61.7M | 9,075,000 | 2.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $60.4M | 4,394,527 | 2.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $50.8M | 3,608,645 | 2.4% |
| Mersana Therapeutics Inc | COM | 59045L106 | $50.7M | 11,328,000 | 2.4% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $43.5M | 2,565,841 | 2.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $43.1M | 706,126 | 2.0% |
| Hillevax Inc | COM | 43157M102 | $34.5M | 2,075,000 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $34.5M | 5,129,167 | 1.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $33.2M | 1,818,182 | 1.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $26.7M | 1,563,952 | 1.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $25.9M | 627,788 | 1.2% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $25.8M | 9,000,000 | 1.2% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $23.7M | 5,555,555 | 1.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $22.4M | 3,410,058 | 1.1% |
| Adverum Biotechnologies Inc(AVU0) | COM NEW | 00773U207 | $22.0M | 1,556,419 | 1.0% |
| Celcuity Inc(CELC) | COM | 15102K100 | $21.0M | 970,000 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $19.2M | 1,345,780 | 0.9% |
| Immatics N.v(IMTX) | SHS | N44445109 | $18.4M | 1,750,000 | 0.9% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $16.0M | 2,576,093 | 0.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $15.4M | 350,000 | 0.7% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $14.2M | 3,405,133 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $11.8M | 3,422,675 | 0.6% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $8.1M | 1,555,556 | 0.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.2M | 555,554 | 0.3% |
| Acelyrin Inc | COM | 00445A100 | $6.3M | 937,113 | 0.3% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $5.2M | 250,000 | 0.2% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $872.1K | 77,042 | 0.0% |